Diagnosis and progression of ALS
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by loss of upper and lower motor neurons, leading to progressive loss of motor function. The disease is almost always fatal, and approximately 50% of patients die within 3 to 4 years after onset of symptoms. [1,2] ALS is more common in men than in women (until age 70, when the rate becomes equal) and, although the average age of onset is in the mid-fifties, the disease can occur at anytime after the teen years. [2-4] The disease is a distinct syndrome characterized by a combination of upper motor neuron (UMN) and lower motor neuron (LMN) dysfunction and by generalized distribution and relentless progression. No specific blood test is available to provide an unequivocal diagnosis of ALS, and the clinical diagnosis is usually based on results of physical and neurologic examinations that identify the signs and symptoms of the disease. Because UMN and LMN symptoms associated with a variety of other disorders mimic those seen in ALS patients, an integral part of diagnosing ALS involves excluding other possible causes of the signs and symptoms exhibited by the patients. Diagnostic tests, such as electromyography (EMG), neuroimaging, blood and urine tests and, if indicated, muscle and nerve biopsy, are therefore used in this process.
Types of ALS, hypotheses of pathogenesis, and need for early diagnosis.
Although ALS was first described more than 120 years ago by Charcot, [5] it has remained an enigmatic disease. Recently, however, as the result of intense research during the past decade, significant advances have been made in understanding the pathogenesis and etiology of ALS and in identifying potential management strategies for the disease.
More than 90% of ALS cases are classified as "classical," a type of sporadic ALS, and are characterized by a combination of UMN and LMN involvement. [2] Among classical ALS patients, more than two-thirds present with …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Types of ALS, hypotheses of pathogenesis, and need for early diagnosis.
- Presenting complaints and initial evaluation of patients with suspected ALS.
- Physical and neurologic examinations used in the initial diagnosis of ALS.
- World Federation of Neurology criteria for diagnosis of ALS.
- Confirmatory evidence.
- Tests used in the diagnosis of ALS.
- Neuroimaging.
- Differential diagnosis of ALS.
- Disease progression and prognosis of ALS.
- Conclusion.
- REFERENCES
- Figures & Data
- Info & Disclosures
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALSP. H. Gordon, B. Cheng, I. B. Katz et al.Neurology, June 01, 2009 -
Articles
Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron diseaseW.J. Triggs, D. Menkes, J. Onorato et al.Neurology, August 01, 1999 -
Articles
Toward earlier diagnosis of amyotrophic lateral sclerosisRevised criteriaM. A. Ross, R. G. Miller, L. Berchert et al.Neurology, March 01, 1998 -
Articles
Focality of upper and lower motor neuron degeneration at the clinical onset of ALSJohn Ravits, Piper Paul, Cathy Jorg et al.Neurology, May 07, 2007